ArticleJournal of clinical medicine2022

Clinical Outcomes of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 Breast Cancer Patients: A Single-Center Retrospective Study.

Chih-Chiang Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.